Key Details
Last Dividend
$0.43Annual EPS
-$0.98Annual ROE
-119.12%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 14, 2024Recent annual earnings:
June 09, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
Feb 08, 2024Next split:
N/ARecent split:
May 08, 2019Analyst ratings
Recent major analysts updates
28 Apr '22 HC Wainwright & Co.
Sell28 Apr '22 Cantor Fitzgerald
Neutral01 Feb '22 SVB Leerink
Market Perform01 Feb '22 HC Wainwright & Co.
Buy21 Oct '21 HC Wainwright & Co.
Buy12 Aug '21 SVB Leerink
Outperform15 June '21 BTIG
Buy30 Apr '21 HC Wainwright & Co.
Buy16 Dec '20 SVB Leerink
OutperformScreeners with SIOX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Sio Gene Therapies?
- What is the ticker symbol for Sio Gene Therapies?
- Does Sio Gene Therapies pay dividends?
- What sector is Sio Gene Therapies in?
- What industry is Sio Gene Therapies in?
- What country is Sio Gene Therapies based in?
- When did Sio Gene Therapies go public?
- Is Sio Gene Therapies in the S&P 500?
- Is Sio Gene Therapies in the NASDAQ 100?
- Is Sio Gene Therapies in the Dow Jones?
- When was Sio Gene Therapies's last earnings report?
- When does Sio Gene Therapies report earnings?
- Should I buy Sio Gene Therapies stock now?
What is the primary business of Sio Gene Therapies?
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.
What is the ticker symbol for Sio Gene Therapies?
The ticker symbol for Sio Gene Therapies is NASDAQ:SIOX
Does Sio Gene Therapies pay dividends?
No, Sio Gene Therapies does not pay dividends
What sector is Sio Gene Therapies in?
Sio Gene Therapies is in the Healthcare sector
What industry is Sio Gene Therapies in?
Sio Gene Therapies is in the Biotechnology industry
What country is Sio Gene Therapies based in?
Sio Gene Therapies is headquartered in United States
When did Sio Gene Therapies go public?
Sio Gene Therapies's initial public offering (IPO) was on 11 June 2015
Is Sio Gene Therapies in the S&P 500?
No, Sio Gene Therapies is not included in the S&P 500 index
Is Sio Gene Therapies in the NASDAQ 100?
No, Sio Gene Therapies is not included in the NASDAQ 100 index
Is Sio Gene Therapies in the Dow Jones?
No, Sio Gene Therapies is not included in the Dow Jones index
When was Sio Gene Therapies's last earnings report?
Sio Gene Therapies's most recent earnings report was on 14 February 2024
When does Sio Gene Therapies report earnings?
The date for Sio Gene Therapies's next earnings report has not been announced yet
Should I buy Sio Gene Therapies stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions